img

Global Typhoid Vaccine Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Typhoid Vaccine Market Insights, Forecast to 2034

Global Typhoid Vaccine market is expected to reach to US$ 12760 million in 2024, with a positive growth of %, compared with US$ 11900 million in 2022. Backed with the increasing demand from downstream industries, Typhoid Vaccine industry is evaluated to reach US$ 16050 million in 2029. The CAGR will be 3.9% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Typhoid Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Typhoid Vaccine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi
Merck
GlaxoSmithKline
PaxVax
Actiza Pharmaceutical
Merit Pharmaceuticals
Bharat Biotec
Segment by Type
Oral Type Typhoid Vaccine
Injection Type Typhoid Vaccine

Segment by Application


Hospital
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Typhoid Vaccine plant distribution, commercial date of Typhoid Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Typhoid Vaccine introduction, etc. Typhoid Vaccine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Typhoid Vaccine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Typhoid Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Typhoid Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Oral Type Typhoid Vaccine
1.2.3 Injection Type Typhoid Vaccine
1.3 Market by Application
1.3.1 Global Typhoid Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Research & Academic Laboratories
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Typhoid Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Typhoid Vaccine Revenue by Region
2.2.1 Global Typhoid Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Typhoid Vaccine Revenue by Region (2018-2024)
2.2.3 Global Typhoid Vaccine Revenue by Region (2024-2029)
2.2.4 Global Typhoid Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Typhoid Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Typhoid Vaccine Sales by Region
2.4.1 Global Typhoid Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Typhoid Vaccine Sales by Region (2018-2024)
2.4.3 Global Typhoid Vaccine Sales by Region (2024-2029)
2.4.4 Global Typhoid Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Typhoid Vaccine Sales by Manufacturers
3.1.1 Global Typhoid Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global Typhoid Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Typhoid Vaccine in 2022
3.2 Global Typhoid Vaccine Revenue by Manufacturers
3.2.1 Global Typhoid Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Typhoid Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Typhoid Vaccine Revenue in 2022
3.3 Global Key Players of Typhoid Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Typhoid Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Typhoid Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Typhoid Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Typhoid Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Typhoid Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Typhoid Vaccine Sales by Type
4.1.1 Global Typhoid Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global Typhoid Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Typhoid Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Typhoid Vaccine Revenue by Type
4.2.1 Global Typhoid Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Typhoid Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Typhoid Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Typhoid Vaccine Price by Type
4.3.1 Global Typhoid Vaccine Price by Type (2018-2024)
4.3.2 Global Typhoid Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Typhoid Vaccine Sales by Application
5.1.1 Global Typhoid Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global Typhoid Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Typhoid Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Typhoid Vaccine Revenue by Application
5.2.1 Global Typhoid Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Typhoid Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Typhoid Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Typhoid Vaccine Price by Application
5.3.1 Global Typhoid Vaccine Price by Application (2018-2024)
5.3.2 Global Typhoid Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Typhoid Vaccine Market Size by Type
6.1.1 US & Canada Typhoid Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Typhoid Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Typhoid Vaccine Market Size by Application
6.2.1 US & Canada Typhoid Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Typhoid Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Typhoid Vaccine Market Size by Country
6.3.1 US & Canada Typhoid Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Typhoid Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Typhoid Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Typhoid Vaccine Market Size by Type
7.1.1 Europe Typhoid Vaccine Sales by Type (2018-2029)
7.1.2 Europe Typhoid Vaccine Revenue by Type (2018-2029)
7.2 Europe Typhoid Vaccine Market Size by Application
7.2.1 Europe Typhoid Vaccine Sales by Application (2018-2029)
7.2.2 Europe Typhoid Vaccine Revenue by Application (2018-2029)
7.3 Europe Typhoid Vaccine Market Size by Country
7.3.1 Europe Typhoid Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Typhoid Vaccine Sales by Country (2018-2029)
7.3.3 Europe Typhoid Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Typhoid Vaccine Market Size
8.1.1 China Typhoid Vaccine Sales (2018-2029)
8.1.2 China Typhoid Vaccine Revenue (2018-2029)
8.2 China Typhoid Vaccine Market Size by Application
8.2.1 China Typhoid Vaccine Sales by Application (2018-2029)
8.2.2 China Typhoid Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Typhoid Vaccine Market Size by Type
9.1.1 Asia Typhoid Vaccine Sales by Type (2018-2029)
9.1.2 Asia Typhoid Vaccine Revenue by Type (2018-2029)
9.2 Asia Typhoid Vaccine Market Size by Application
9.2.1 Asia Typhoid Vaccine Sales by Application (2018-2029)
9.2.2 Asia Typhoid Vaccine Revenue by Application (2018-2029)
9.3 Asia Typhoid Vaccine Sales by Region
9.3.1 Asia Typhoid Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Typhoid Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Typhoid Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Typhoid Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Typhoid Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Typhoid Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Typhoid Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Typhoid Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Typhoid Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Typhoid Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Typhoid Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Typhoid Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Typhoid Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Typhoid Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Sanofi Typhoid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Overview
11.2.3 Merck Typhoid Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Merck Typhoid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Overview
11.3.3 GlaxoSmithKline Typhoid Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 GlaxoSmithKline Typhoid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GlaxoSmithKline Recent Developments
11.4 PaxVax
11.4.1 PaxVax Company Information
11.4.2 PaxVax Overview
11.4.3 PaxVax Typhoid Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 PaxVax Typhoid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 PaxVax Recent Developments
11.5 Actiza Pharmaceutical
11.5.1 Actiza Pharmaceutical Company Information
11.5.2 Actiza Pharmaceutical Overview
11.5.3 Actiza Pharmaceutical Typhoid Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Actiza Pharmaceutical Typhoid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Actiza Pharmaceutical Recent Developments
11.6 Merit Pharmaceuticals
11.6.1 Merit Pharmaceuticals Company Information
11.6.2 Merit Pharmaceuticals Overview
11.6.3 Merit Pharmaceuticals Typhoid Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Merit Pharmaceuticals Typhoid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Merit Pharmaceuticals Recent Developments
11.7 Bharat Biotec
11.7.1 Bharat Biotec Company Information
11.7.2 Bharat Biotec Overview
11.7.3 Bharat Biotec Typhoid Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Bharat Biotec Typhoid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bharat Biotec Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Typhoid Vaccine Industry Chain Analysis
12.2 Typhoid Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Typhoid Vaccine Production Mode & Process
12.4 Typhoid Vaccine Sales and Marketing
12.4.1 Typhoid Vaccine Sales Channels
12.4.2 Typhoid Vaccine Distributors
12.5 Typhoid Vaccine Customers
13 Market Dynamics
13.1 Typhoid Vaccine Industry Trends
13.2 Typhoid Vaccine Market Drivers
13.3 Typhoid Vaccine Market Challenges
13.4 Typhoid Vaccine Market Restraints
14 Key Findings in The Global Typhoid Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Typhoid Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Oral Type Typhoid Vaccine
Table 3. Major Manufacturers of Injection Type Typhoid Vaccine
Table 4. Global Typhoid Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Typhoid Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Typhoid Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Typhoid Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Typhoid Vaccine Revenue Market Share by Region (2018-2024)
Table 9. Global Typhoid Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Typhoid Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Typhoid Vaccine Sales by Region (2018-2024) & (K Units)
Table 12. Global Typhoid Vaccine Sales by Region (2024-2029) & (K Units)
Table 13. Global Typhoid Vaccine Sales Market Share by Region (2018-2024)
Table 14. Global Typhoid Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Typhoid Vaccine Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Typhoid Vaccine Sales Share by Manufacturers (2018-2024)
Table 17. Global Typhoid Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Typhoid Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Typhoid Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Typhoid Vaccine Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Typhoid Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Typhoid Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Typhoid Vaccine as of 2022)
Table 23. Global Key Manufacturers of Typhoid Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Typhoid Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Typhoid Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Typhoid Vaccine Sales by Type (2018-2024) & (K Units)
Table 28. Global Typhoid Vaccine Sales by Type (2024-2029) & (K Units)
Table 29. Global Typhoid Vaccine Sales Share by Type (2018-2024)
Table 30. Global Typhoid Vaccine Sales Share by Type (2024-2029)
Table 31. Global Typhoid Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Typhoid Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Typhoid Vaccine Revenue Share by Type (2018-2024)
Table 34. Global Typhoid Vaccine Revenue Share by Type (2024-2029)
Table 35. Typhoid Vaccine Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Typhoid Vaccine Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Typhoid Vaccine Sales by Application (2018-2024) & (K Units)
Table 38. Global Typhoid Vaccine Sales by Application (2024-2029) & (K Units)
Table 39. Global Typhoid Vaccine Sales Share by Application (2018-2024)
Table 40. Global Typhoid Vaccine Sales Share by Application (2024-2029)
Table 41. Global Typhoid Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Typhoid Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Typhoid Vaccine Revenue Share by Application (2018-2024)
Table 44. Global Typhoid Vaccine Revenue Share by Application (2024-2029)
Table 45. Typhoid Vaccine Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Typhoid Vaccine Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Typhoid Vaccine Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Typhoid Vaccine Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Typhoid Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Typhoid Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Typhoid Vaccine Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Typhoid Vaccine Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Typhoid Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Typhoid Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Typhoid Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Typhoid Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Typhoid Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Typhoid Vaccine Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Typhoid Vaccine Sales by Country (2024-2029) & (K Units)
Table 60. Europe Typhoid Vaccine Sales by Type (2018-2024) & (K Units)
Table 61. Europe Typhoid Vaccine Sales by Type (2024-2029) & (K Units)
Table 62. Europe Typhoid Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Typhoid Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Typhoid Vaccine Sales by Application (2018-2024) & (K Units)
Table 65. Europe Typhoid Vaccine Sales by Application (2024-2029) & (K Units)
Table 66. Europe Typhoid Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Typhoid Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Typhoid Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Typhoid Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Typhoid Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Typhoid Vaccine Sales by Country (2018-2024) & (K Units)
Table 72. Europe Typhoid Vaccine Sales by Country (2024-2029) & (K Units)
Table 73. China Typhoid Vaccine Sales by Type (2018-2024) & (K Units)
Table 74. China Typhoid Vaccine Sales by Type (2024-2029) & (K Units)
Table 75. China Typhoid Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Typhoid Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Typhoid Vaccine Sales by Application (2018-2024) & (K Units)
Table 78. China Typhoid Vaccine Sales by Application (2024-2029) & (K Units)
Table 79. China Typhoid Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Typhoid Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Typhoid Vaccine Sales by Type (2018-2024) & (K Units)
Table 82. Asia Typhoid Vaccine Sales by Type (2024-2029) & (K Units)
Table 83. Asia Typhoid Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Typhoid Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Typhoid Vaccine Sales by Application (2018-2024) & (K Units)
Table 86. Asia Typhoid Vaccine Sales by Application (2024-2029) & (K Units)
Table 87. Asia Typhoid Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Typhoid Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Typhoid Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Typhoid Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Typhoid Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Typhoid Vaccine Sales by Region (2018-2024) & (K Units)
Table 93. Asia Typhoid Vaccine Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Typhoid Vaccine Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Typhoid Vaccine Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Typhoid Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Typhoid Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Typhoid Vaccine Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Typhoid Vaccine Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Typhoid Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Typhoid Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Typhoid Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Typhoid Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Typhoid Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Typhoid Vaccine Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Typhoid Vaccine Sales by Country (2024-2029) & (K Units)
Table 107. Sanofi Company Information
Table 108. Sanofi Description and Major Businesses
Table 109. Sanofi Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Sanofi Typhoid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sanofi Recent Developments
Table 112. Merck Company Information
Table 113. Merck Description and Major Businesses
Table 114. Merck Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Merck Typhoid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Merck Recent Developments
Table 117. GlaxoSmithKline Company Information
Table 118. GlaxoSmithKline Description and Major Businesses
Table 119. GlaxoSmithKline Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. GlaxoSmithKline Typhoid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. GlaxoSmithKline Recent Developments
Table 122. PaxVax Company Information
Table 123. PaxVax Description and Major Businesses
Table 124. PaxVax Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. PaxVax Typhoid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. PaxVax Recent Developments
Table 127. Actiza Pharmaceutical Company Information
Table 128. Actiza Pharmaceutical Description and Major Businesses
Table 129. Actiza Pharmaceutical Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Actiza Pharmaceutical Typhoid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Actiza Pharmaceutical Recent Developments
Table 132. Merit Pharmaceuticals Company Information
Table 133. Merit Pharmaceuticals Description and Major Businesses
Table 134. Merit Pharmaceuticals Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Merit Pharmaceuticals Typhoid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Merit Pharmaceuticals Recent Developments
Table 137. Bharat Biotec Company Information
Table 138. Bharat Biotec Description and Major Businesses
Table 139. Bharat Biotec Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Bharat Biotec Typhoid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Bharat Biotec Recent Developments
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Typhoid Vaccine Distributors List
Table 145. Typhoid Vaccine Customers List
Table 146. Typhoid Vaccine Market Trends
Table 147. Typhoid Vaccine Market Drivers
Table 148. Typhoid Vaccine Market Challenges
Table 149. Typhoid Vaccine Market Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Typhoid Vaccine Product Picture
Figure 2. Global Typhoid Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Typhoid Vaccine Market Share by Type in 2022 & 2029
Figure 4. Oral Type Typhoid Vaccine Product Picture
Figure 5. Injection Type Typhoid Vaccine Product Picture
Figure 6. Global Typhoid Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Typhoid Vaccine Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Research & Academic Laboratories
Figure 10. Pharmaceutical & Biotechnology Companies
Figure 11. Others
Figure 12. Typhoid Vaccine Report Years Considered
Figure 13. Global Typhoid Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Typhoid Vaccine Revenue 2018-2029 (US$ Million)
Figure 15. Global Typhoid Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Typhoid Vaccine Revenue Market Share by Region (2018-2029)
Figure 17. Global Typhoid Vaccine Sales 2018-2029 ((K Units)
Figure 18. Global Typhoid Vaccine Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Typhoid Vaccine Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Typhoid Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Typhoid Vaccine Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Typhoid Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Typhoid Vaccine Sales YoY (2018-2029) & (K Units)
Figure 24. China Typhoid Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Typhoid Vaccine Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Typhoid Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Typhoid Vaccine Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Typhoid Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Typhoid Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Typhoid Vaccine in the World: Market Share by Typhoid Vaccine Revenue in 2022
Figure 31. Global Typhoid Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Typhoid Vaccine Sales Market Share by Type (2018-2029)
Figure 33. Global Typhoid Vaccine Revenue Market Share by Type (2018-2029)
Figure 34. Global Typhoid Vaccine Sales Market Share by Application (2018-2029)
Figure 35. Global Typhoid Vaccine Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Typhoid Vaccine Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Typhoid Vaccine Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Typhoid Vaccine Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Typhoid Vaccine Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Typhoid Vaccine Revenue Share by Country (2018-2029)
Figure 41. US & Canada Typhoid Vaccine Sales Share by Country (2018-2029)
Figure 42. U.S. Typhoid Vaccine Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Typhoid Vaccine Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Typhoid Vaccine Sales Market Share by Type (2018-2029)
Figure 45. Europe Typhoid Vaccine Revenue Market Share by Type (2018-2029)
Figure 46. Europe Typhoid Vaccine Sales Market Share by Application (2018-2029)
Figure 47. Europe Typhoid Vaccine Revenue Market Share by Application (2018-2029)
Figure 48. Europe Typhoid Vaccine Revenue Share by Country (2018-2029)
Figure 49. Europe Typhoid Vaccine Sales Share by Country (2018-2029)
Figure 50. Germany Typhoid Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. France Typhoid Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Typhoid Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Typhoid Vaccine Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Typhoid Vaccine Revenue (2018-2029) & (US$ Million)
Figure 55. China Typhoid Vaccine Sales Market Share by Type (2018-2029)
Figure 56. China Typhoid Vaccine Revenue Market Share by Type (2018-2029)
Figure 57. China Typhoid Vaccine Sales Market Share by Application (2018-2029)
Figure 58. China Typhoid Vaccine Revenue Market Share by Application (2018-2029)
Figure 59. Asia Typhoid Vaccine Sales Market Share by Type (2018-2029)
Figure 60. Asia Typhoid Vaccine Revenue Market Share by Type (2018-2029)
Figure 61. Asia Typhoid Vaccine Sales Market Share by Application (2018-2029)
Figure 62. Asia Typhoid Vaccine Revenue Market Share by Application (2018-2029)
Figure 63. Asia Typhoid Vaccine Revenue Share by Region (2018-2029)
Figure 64. Asia Typhoid Vaccine Sales Share by Region (2018-2029)
Figure 65. Japan Typhoid Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Typhoid Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Typhoid Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Typhoid Vaccine Revenue (2018-2029) & (US$ Million)
Figure 69. India Typhoid Vaccine Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Typhoid Vaccine Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Typhoid Vaccine Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Typhoid Vaccine Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Typhoid Vaccine Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Typhoid Vaccine Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Typhoid Vaccine Sales Share by Country (2018-2029)
Figure 76. Brazil Typhoid Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Typhoid Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Typhoid Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Typhoid Vaccine Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Typhoid Vaccine Revenue (2018-2029) & (US$ Million)
Figure 81. Typhoid Vaccine Value Chain
Figure 82. Typhoid Vaccine Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries